Neuralstem Phase 1 Data Gives Hope In ALS

Data from the Phase 1 trial of Neuralstem's NSI-566 in Amyotrophic Lateral Sclerosis patients was presented at the 2013 American Neurology Association Meeting in October 2013 and is being published in the Annals of Neurology .

http://ift.tt/1cm8FUq